Purchases and Sales Made in Q1 2022 in Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX) during Q1 2022. The information is specifically focused on institutions that hold shares of EAGLE PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-75.6KClosed |
$3.37M - $3.98M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-88.3K- 95.3% |
$3.94M - $4.65M
|
4.36K
$2.62K
|
|
|
May 16, 2022
Q1 2022
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-122KClosed |
$5.43M - $6.4M
|
0
$0
|
|
|
Apr 26, 2022
Q1 2022
|
Chartwell Investment Partners, LLC
|
SELL
|
- |
-173KClosed |
$7.72M - $9.11M
|
0
$0
|
|
|
May 10, 2022
Q1 2022
|
Brandes Investment Partners, LP
La Jolla, CA |
SELL
|
- |
-183K- 29.71% |
$8.14M - $9.6M
|
432K
$259K
|